News
07-15-2010, 05:00 AM
Plexxikon Inc. today announced promising preclinical data from in vivo Alzheimer's Disease studies demonstrating a dramatic reduction in activated microglia in the brains of very old (22 months) 3xTG-AD mice, a triple transgenic model for Alzheimer's Disease. This reduction of activated microglia led to significantly improved learning in the treated group.
More... (http://www.news-medical.net/news/20100715/Plexxikon-announces-promising-preclinical-data-of-PLX3397.aspx)
More... (http://www.news-medical.net/news/20100715/Plexxikon-announces-promising-preclinical-data-of-PLX3397.aspx)